Macro Biologics, Inc.
Developer of engineered large-molecule biologics composed of amino-acid polymers for topical prevention and treatment of infections. The company designs, patents, formulates, and manufactures polymer-based biologics for healthcare and other industries, with development programs focused on locally applied antimicrobial materials and product formulations for surgery, trauma, and field care.
Industries
N/A
Nr. of Employees
small (1-50)
Macro Biologics, Inc.
3142 Tiger Run Court - Suite 101, Carlsbad, California 92010
Products
Topical surgical gel (amino-acid polymer)
A locally applied gel formulation based on engineered amino-acid polymers designed to prevent surgical and traumatic wound infections by forming a physical barrier and providing microbicidal activity.
Topical antimicrobial solution (amino-acid polymer)
A solution formulation intended to treat tissues contaminated or infected with bacteria and yeast, designed for local application and irrigation.
Prolonged Field Care topical formulation
A clinical formulation developed for prolonged field care (PFC) to support battlefield or austere environment wound management.
Topical surgical gel (amino-acid polymer)
A locally applied gel formulation based on engineered amino-acid polymers designed to prevent surgical and traumatic wound infections by forming a physical barrier and providing microbicidal activity.
Topical antimicrobial solution (amino-acid polymer)
A solution formulation intended to treat tissues contaminated or infected with bacteria and yeast, designed for local application and irrigation.
Prolonged Field Care topical formulation
A clinical formulation developed for prolonged field care (PFC) to support battlefield or austere environment wound management.
Services
Co-development and partnering for new products using engineered polymer biologics, including formulation and application development.
Co-development and partnering for new products using engineered polymer biologics, including formulation and application development.
Expertise Areas
- Polymer-based biologic design
- Topical antimicrobial product development
- GMP manufacturing scale-up for biologics
- Preclinical GLP toxicology and validation
Key Technologies
- Amino-acid polymer synthesis
- Polymeric formulation for topical delivery
- GMP-compliant manufacturing processes
- GLP toxicology studies
News & Updates
Company CEO presented technology platform and lead product candidates at the BIO International Convention.
Scheduled presentation on investigational products and potential to prevent early microbial invasion progressing to sepsis.
Announcement of kilogram-scale GMP production of lead polymer biologics in collaboration with a contract manufacturer experienced in amino-acid polymer synthesis and characterization.
Announcement of selected clinical formulation for a prolonged field care topical product supported by Department of Defense funding.
Corporate name change to better reflect the company's broader technology platform and product opportunities.
Multi-year collaboration and corporate investment focused on development of biodegradable antimicrobial peptides for skin care and healthcare applications.
Company CEO presented technology platform and lead product candidates at the BIO International Convention.
Scheduled presentation on investigational products and potential to prevent early microbial invasion progressing to sepsis.
Announcement of kilogram-scale GMP production of lead polymer biologics in collaboration with a contract manufacturer experienced in amino-acid polymer synthesis and characterization.
Announcement of selected clinical formulation for a prolonged field care topical product supported by Department of Defense funding.
Corporate name change to better reflect the company's broader technology platform and product opportunities.
Multi-year collaboration and corporate investment focused on development of biodegradable antimicrobial peptides for skin care and healthcare applications.